Abstract:Circulation, Volume 146, Issue Suppl_1, Page A13254-A13254, November 8, 2022. Background:Klotho is an anti-aging protein expressed primarily in the kidney and vasculature. Chronic kidney disease (CKD) results in hyperphosphatemia. We reported that high levels of phosphate downregulate Klotho expression in vascular cells. Endothelial-to-mesenchymal transition (EndMT) in arteries promotes the development of atherosclerosis, and CKD is a significant risk factor for atherosclerosis. However, the impact of CKD on EndMT in arteries is unclear and whether Klotho insufficiency plays a role in the mechanism underlying vascular EndMT remains unknown. This study tested thehypothesisthat Klotho insufficiency associated with CKD induces senescence in arterial endothelial cells to upregulate EndMT.Methods and Results:We developed a CKD model in C57/BL6 mice (5-6 months old) on AIN-76A diet and treated with adenine and calcitriol.CKD was confirmed by markedly elevated blood levels of creatinine and phosphate, as well as by renal tubular damage. En face immunofluorescence staining of aorta and image quantification revealed that the levels of biomarkers of senescence (P21) and EndMT (vimentin) were greater, while Klotho levels were lower, in the aortic arch endothelial cells of CKD mice compared to sham control mice. P21 and vimentin were co-localized in a greater number of endothelial cells in the aortic arch of CKD mice. High phosphate treatment upregulated the levels of P21 and vimentin and reduced the levels of Klotho in both primary human and mouse aortic endothelial cells, and knockdown P21 attenuated EndMT induced by high phosphate. Recombinant Klotho suppressed both senescence and EndMT in primary human aortic endothelial cells. Further, prolonged treatment of CKD mice with recombinant Klotho attenuated endothelial senescence and EndMT in the aortic arch.Conclusion:Klotho insufficiency associated with CKD promotes endothelial senescence and EndMT in aorta. High phosphate is capable of inducing endothelial senescent change that provokes EndMT. Administration of recombinant Klotho or upregulation of Klotho expression may have therapeutic potential for suppressing pro-atherosclerosis activity in large arteries by prevention of endothelial senescence and resultant EndMT.

Klotho Depletion Contributes to Increased Inflammation in Kidney of the db/db Mouse Model of Diabetes via RelA (Serine)536 Phosphorylation

Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice

Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-κB signaling pathway in senescence-accelerated mice

Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease

Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging

Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice

Klotho Inhibits PKCα/p66SHC-mediated Podocyte Injury in Diabetic Nephropathy

Klotho Attenuates Diabetic Nephropathy in Db/db Mice and Ameliorates High Glucose-Induced Injury of Human Renal Glomerular Endothelial Cells.

Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes

Klotho retards renal fibrosis through targeting mitochondrial dysfunction and cellular senescence in renal tubular cells

Nanoparticle-mediated Klotho Gene Therapy Prevents Acute Kidney Injury to Chronic Kidney Disease Transition Through Regulating PPARα Signaling in Renal Tubular Epithelial Cells

Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism

Abstract 13254: Klotho Suppresses Endothelial-to-Mesenchymal Transition in the Aorta of Mice With Chronic Kidney Disease by Inhibition of Endothelial Senescent Activity

Klotho Down-Regulates Egr-1 by Inhibiting TGF-β1/Smad3 Signaling in High Glucose Treated Human Mesangial Cells.

Klotho Preservation by Rhein Promotes Toll-Like Receptor 4 Proteolysis and Attenuates Lipopolysaccharide-Induced Acute Kidney Injury.

CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation

Abstract 16868: Conditional Renal Tubule Specific Deletion of KDM6a Gene Causes Hypertension in Mice

New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms

Long Noncoding RNA NEAT1 is Involved in the Protective Effect of Klotho on Renal Tubular Epithelial Cells in Diabetic Kidney Disease Through the ERK1/2 Signaling Pathway

Klotho increases antioxidant defenses in astrocytes and ubiquitin-proteasome activity in neurons

Upstream and Downstream Regulators of Klotho Expression in Chronic Kidney Disease